Thought-Controlled Bionic Arm for Arm Amputees
(iSens Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this research is to gather information on the safety and effectiveness of an implanted wireless sensory enabled highly intuitive controlled prosthetic device.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you use any active medical devices that are necessary for your health, you may not be eligible to participate.
What data supports the effectiveness of the treatment iSens, iSense optical scanner, and Implantable Myoelectric Sensors (IMES) for arm amputees?
Research shows that implantable myoelectric sensors can help amputees control prosthetic limbs more naturally by detecting muscle signals directly, allowing for better movement control. Additionally, studies indicate that providing feedback to the brain about limb movement can improve control of prosthetic hands, suggesting that these technologies can enhance the effectiveness of bionic arms.12345
Is the thought-controlled bionic arm safe for human use?
How is the iSens treatment different from other treatments for arm amputees?
Research Team
Dustin J. Tyler, PhD
Principal Investigator
Louis Stokes VA Medical Center, Cleveland, OH
Eligibility Criteria
This trial is for adults over 21 who have had an upper limb amputation at least 6 months ago and are using or prescribed a myoelectric prosthesis. They must be mentally fit to participate, as confirmed by a psychologist, and have healthy nerves in the affected limb. People with poor wound healing, infections, pregnancy, inability to speak English, arthritis near the implant area or those needing MRI scans can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgical Implantation
Surgical implant of cuff electrodes on residual nerves and muscle recording electrodes in muscles, connected to an implanted stimulator
Treatment
Participants use the iSens system or their own prosthesis for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- iSens
iSens is already approved in United States for the following indications:
- Residual limb volume measurement
- Control of externally powered prosthetics
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
United States Department of Defense
Collaborator
Defense Advanced Research Projects Agency
Collaborator